Diagnostic performance of procalcitonin for bacteremia in patients with severe dengue infection in the intensive care unit

Journal of Infection

Volumn 73, Issue 1, 2016, Pages 93-95

  Chen, Chin Ming ^a   Chan, Khee Siang ^b   Chao, Hui Chun ^b   Lai, Chih Cheng ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; CALCITONIN;

ABDOMINAL PAIN; AGED; APACHE; BACTEREMIA; BACTERIAL INFECTION; CLINICAL FEATURE; COMORBIDITY; CONTINUOUS RENAL REPLACEMENT THERAPY; DENGUE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; LETTER; MAJOR CLINICAL STUDY; MALE; MECHANICAL VENTILATOR; MIXED INFECTION; MORTALITY; PATHOGENESIS; PNEUMONIA; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; URINARY TRACT INFECTION; BLOOD; SEVERE DENGUE;

AGED; BACTEREMIA; CALCITONIN; COINFECTION; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERE DENGUE;

EID: 84973402356     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2016.03.013     Document Type: Letter

References (10)

1. Rodriguez A.H., Aviles-Jurado F.X., Diaz E., Schuetz P., Trefler S.I., Sole-Violan J., et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect 2016, 72(2):143-151.
2. Brechot N., Hekimian G., Chastre J., Luyt C.E. Procalcitonin to guide antibiotic therapy in the ICU. Int J Antimicrob Agents 2015, 46(Suppl. 1):S19-S24.
3. Mandell I.M., Aghamohammadi S., Deakers T., Khemani R.G. Procalcitonin to detect suspected bacterial infections in the PICU. Pediatr Crit Care Med 2016, 17(1):e4-e12.
4. Shi Y., Peng J.M., Hu X.Y., Wang Y. The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study. BMC Anesthesiol 2015, 15:137.
5. Murray N.E., Quam M.B., Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol 2013, 5:299-309.
6. Guzman M.G., Harris E. Dengue. Lancet 2015, 385(9966):453-465.
7. Halstead S.B. Dengue. Lancet 2007, 370(9599):1644-1652.
8. Amancio F.F., Heringer T.P., de Oliveira Cda C., Fassy L.B., de Carvalho F.B., Oliveira D.P., et al. Clinical profiles and factors associated with death in adults with dengue admitted to intensive care units, Minas Gerais, Brazil. PLoS One 2015, 10(6):e0129046.
9. Lai C.C., Chen S.Y., Wang C.Y., Wang J.Y., Su C.P., Liao C.H., et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients in the emergency department. J Am Geriatr Soc 2010, 58(3):518-522.
10. Lai C.C., Tan C.K., Chen S.Y., Wang C.Y., Liu W.L., Hou C.C., et al. Diagnostic performance of procalcitonin for bacteremia in patients with bacterial infection at the emergency department. J Infect 2010, 61(6):512-515.